| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Stryker Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$290.51 |
| 52 Week High | US$306.93 |
| 52 Week Low | US$233.96 |
| Beta | 0.95 |
| 1 Month Change | 5.17% |
| 3 Month Change | 0.49% |
| 1 Year Change | 23.34% |
| 3 Year Change | 23.39% |
| 5 Year Change | 69.24% |
| Change since IPO | 18,680.44% |
Recent News & Updates
Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10
Recent updates
Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
Aug 22Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Jul 18Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price
Jul 06These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well
Jun 17Stryker: Good Prospects
Jun 14With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case
May 24Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?
May 01Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Apr 18Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Apr 06Is Stryker (NYSE:SYK) Using Too Much Debt?
Feb 27Stryker: Typically Excellent, Typically Expensive
Feb 16Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback
Feb 07If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity
Feb 02Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M
Jan 31Stryker initiated at sector weight by KeyBanc on limited upside potential
Jan 25Stryker: Excellent Recent And Continuing Performance
Jan 09Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital
Jan 08At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Dec 26Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Dec 12Stryker lifts dividend by 7.9% to $0.75/share
Dec 07Stryker Q3 2022 Earnings Preview
Oct 28Stryker (NYSE:SYK) Has A Pretty Healthy Balance Sheet
Oct 28Stryker - A Leading MedTech Company Worth A Second Look
Oct 08Stryker (NYSE:SYK) Will Be Hoping To Turn Its Returns On Capital Around
Oct 04Stryker receives FDA approval for Optablate bone tumor ablation system
Sep 20At US$220, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Sep 09Is There An Opportunity With Stryker Corporation's (NYSE:SYK) 27% Undervaluation?
Aug 27Stryker Is A Moat-Worthy Buy, Here's Why
Aug 03Shareholder Returns
| SYK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.5% | 1.2% | 0.6% |
| 1Y | 23.3% | 0.1% | 14.6% |
Return vs Industry: SYK exceeded the US Medical Equipment industry which returned 0.1% over the past year.
Return vs Market: SYK exceeded the US Market which returned 14.6% over the past year.
Price Volatility
| SYK volatility | |
|---|---|
| SYK Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SYK is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SYK's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 51,000 | Kevin Lobo | https://www.stryker.com |
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.
Stryker Corporation Fundamentals Summary
| SYK fundamental statistics | |
|---|---|
| Market Cap | US$110.53b |
| Earnings (TTM) | US$2.59b |
| Revenue (TTM) | US$19.89b |
42.7x
P/E Ratio5.6x
P/S RatioIs SYK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SYK income statement (TTM) | |
|---|---|
| Revenue | US$19.89b |
| Cost of Revenue | US$7.24b |
| Gross Profit | US$12.65b |
| Other Expenses | US$10.06b |
| Earnings | US$2.59b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.80 |
| Gross Margin | 63.61% |
| Net Profit Margin | 13.00% |
| Debt/Equity Ratio | 70.9% |
How did SYK perform over the long term?
See historical performance and comparison